Cargando…
Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665241/ http://dx.doi.org/10.1182/blood-2022-168809 |
| _version_ | 1784831247670837248 |
|---|---|
| author | Minoia, Carla Bavaro, Davide Loseto, Giacomo Pasciolla, Crescenza Diella, Lucia Pelligrino, Carmen Totaro, Valentina Spada, Vito Camporeale, Michele Attolico, Immacolata Perrone, Tommasina Clemente, Felice di Gennaro, Francesco Musto, Pellegrino Guarini, Attilio Saracino, Annalisa |
| author_facet | Minoia, Carla Bavaro, Davide Loseto, Giacomo Pasciolla, Crescenza Diella, Lucia Pelligrino, Carmen Totaro, Valentina Spada, Vito Camporeale, Michele Attolico, Immacolata Perrone, Tommasina Clemente, Felice di Gennaro, Francesco Musto, Pellegrino Guarini, Attilio Saracino, Annalisa |
| author_sort | Minoia, Carla |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665241 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652412022-11-16 Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure Minoia, Carla Bavaro, Davide Loseto, Giacomo Pasciolla, Crescenza Diella, Lucia Pelligrino, Carmen Totaro, Valentina Spada, Vito Camporeale, Michele Attolico, Immacolata Perrone, Tommasina Clemente, Felice di Gennaro, Francesco Musto, Pellegrino Guarini, Attilio Saracino, Annalisa Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665241/ http://dx.doi.org/10.1182/blood-2022-168809 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Minoia, Carla Bavaro, Davide Loseto, Giacomo Pasciolla, Crescenza Diella, Lucia Pelligrino, Carmen Totaro, Valentina Spada, Vito Camporeale, Michele Attolico, Immacolata Perrone, Tommasina Clemente, Felice di Gennaro, Francesco Musto, Pellegrino Guarini, Attilio Saracino, Annalisa Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure |
| title | Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure |
| title_full | Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure |
| title_fullStr | Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure |
| title_full_unstemmed | Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure |
| title_short | Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure |
| title_sort | oral antiviral therapy and monoclonal antibody for the treatment of covid-19 infection in outpatients receiving anti-cancer treatment for hematological malignancies: a multicenter prospective study exploring efficacy, safety and predictors of covid-19 lung failure |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665241/ http://dx.doi.org/10.1182/blood-2022-168809 |
| work_keys_str_mv | AT minoiacarla oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT bavarodavide oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT losetogiacomo oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT pasciollacrescenza oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT diellalucia oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT pelligrinocarmen oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT totarovalentina oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT spadavito oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT camporealemichele oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT attolicoimmacolata oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT perronetommasina oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT clementefelice oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT digennarofrancesco oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT mustopellegrino oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT guariniattilio oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure AT saracinoannalisa oralantiviraltherapyandmonoclonalantibodyforthetreatmentofcovid19infectioninoutpatientsreceivinganticancertreatmentforhematologicalmalignanciesamulticenterprospectivestudyexploringefficacysafetyandpredictorsofcovid19lungfailure |